|
|
Article: Rosetta Biosoftware Licenses the Syllego[TM] System to Stanford University.
- Article from:
- Business Wire
- Article date:
- March 31, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE -- Rosetta Biosoftware today announced that Stanford University has licensed the Syllego[TM] system for the management and analysis of genetic data produced by the GENEticS of Insulin Sensitivity (GENESIS) consortium. GENESIS researchers in the Quertermous lab at Stanford University will use the Syllego system to support genome-wide association studies (GWAS) targeted at the genetic mechanisms underlying insulin sensitivity.
To date, diabetes-related GWAS have revealed genes associated with insulin production and have not focused on sensitivity to insulin in peripheral tissues. Insulin sensitivity is believed to be largely determined at the genetic level. ...